Crystallization (Comment) | Organism |
---|---|
docking calculations for substrates 3-(aminomethyl)benzoic acid, [3-(aminomethyl)phenyl]acetic acid and [2-(aminomethyl)phenyl]acetic acid, using the crystallographic structure of the enzyme in complex with vigabatrin | Sus scrofa |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-(aminomethyl)benzoic acid | poor competitive inhibitor | Sus scrofa | |
[2-(aminomethyl)phenyl]acetic acid | poor competitive inhibitor | Sus scrofa | |
[3-(aminomethyl)phenyl]acetic acid | poor competitive inhibitor | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | P80147 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
3-(aminomethyl)benzoic acid + 2-oxoglutarate | 3.4% of the activity with 4-aminobutanoate | Sus scrofa | 3-(iminomethyl)benzoic acid + L-glutamate | - |
? | |
4-aminobutanoate + 2-oxoglutarate | - |
Sus scrofa | 4-oxobutanoate + L-glutamate | - |
? | |
[2-(aminomethyl)phenyl]acetic acid + 2-oxoglutarate | 5.65% of the activity with 4-aminobutanoate | Sus scrofa | (2-formylphenyl)acetic acid + L-glutamate | - |
? | |
[3-(aminomethyl)phenyl]acetic acid + 2-oxoglutarate | 0.78% of the activity with 4-aminobutanoate | Sus scrofa | (3-formylphenyl)acetic acid + L-glutamate | - |
? |